Healthcare


 Why is Bruker Corporation (BRKR) Featured in The London Company SMID Cap Strategy?

Why is Bruker Corporation (BRKR) Featured in The London Company SMID Cap Strategy?

February 26, 2025 08:01 AM PST| By Team Kalkine Media

Headlines,Bruker Corporation,(NASDAQ:BRKR),specializes in scientific instruments and diagnostic solutions.,The stock experienced a one-month return of -9.12% and a year-over-year decrease of 39.08%.,Bruker Corporation closed at $50.99 per share on Fe...

 What Is Driving Recent Moves in Agios Pharmaceuticals?

What Is Driving Recent Moves in Agios Pharmaceuticals?

February 26, 2025 01:53 AM PST| By Team Kalkine Media

Highlights:,Institutional investment groups adjusted positions in recent quarters.,Key firms such as Venturi Wealth Management LLC and Mirae Asset Global Investments increased share quantities.,Financial metrics and trading ranges reflect an evolving...

 Can This Biopharma Innovator Revolutionize Blood Disorder Treatment?

Can This Biopharma Innovator Revolutionize Blood Disorder Treatment?

February 26, 2025 01:20 AM PST| By Team Kalkine Media

Highlights,Institutional investors reconfigured ownership.,Quarterly earnings per share exceeded expectations.,Peptide-based therapies advancing in clinical trials.,Protagonist Therapeutics (NASDAQ:PTGX) is a dynamic biopharmaceutical company operati...

 Is Amarin Changing the Face of Cardiovascular Health?

Is Amarin Changing the Face of Cardiovascular Health?

February 26, 2025 12:29 AM PST| By Team Kalkine Media

Highlights,Amarin Corporation (NASDAQ:AMRN) opened at a modest price with a slight upward movement.,Institutional investors and hedge funds maintain active involvement in the firm.,The company emphasizes a global rollout of its flagship cardiovascula...

 Analysts Assign Viking Therapeutics, Inc. (NASDAQ:VKTX) an Average Rating of

Analysts Assign Viking Therapeutics, Inc. (NASDAQ:VKTX) an Average Rating of "Buy"

February 25, 2025 11:28 PM PST| By Team Kalkine Media

Highlight,Viking Therapeutics has garnered significant attention from analysts, with a strong majority recommending a buy rating.,There has been notable insider activity, with key executives reducing their stake in the company.,Institutional investor...

 A Comparative Analysis: Green Thumb Industries (GTBIF) vs. Its Competitors

A Comparative Analysis: Green Thumb Industries (GTBIF) vs. Its Competitors

February 25, 2025 11:26 PM PST| By Team Kalkine Media

Highlights,Green Thumb Industries outperforms competitors in profitability metrics despite having a higher valuation.,Institutional and insider ownership points to moderate confidence in Green Thumb's market potential compared to peers.,Green Thumb e...

 Which Digital Platform Excels in Market Metrics?

Which Digital Platform Excels in Market Metrics?

February 25, 2025 10:23 PM PST| By Team Kalkine Media

Highlights,GoodRx (NASDAQ:GDRX) offers affordable healthcare technology solutions.,Upwork (NASDAQ:UPWK) delivers robust profitability in the digital marketplace.,Distinct financial profiles emerge through volatility, earnings, and ownership concentra...

 Is This the Strongest Medical Stock Right Now?

Is This the Strongest Medical Stock Right Now?

February 25, 2025 10:23 PM PST| By Team Kalkine Media

Highlights,Market Stability:,Co-Diagnostics (NASDAQ:CODX) shows lower market fluctuations compared to the S&P 500, while Globus Medical (NYSE:GMED) exhibits greater market movement.,Financial Strength:,Globus Medical reports significantly higher reve...

 Could Innovative Medical Strategies Redefine Healthcare?

Could Innovative Medical Strategies Redefine Healthcare?

February 25, 2025 10:23 PM PST| By Team Kalkine Media

Highlights:,Extensive institutional investor involvement for Corcept Therapeutics compared to moderate stakeholder support for Amarillo Biosciences.,Market stability observed in Corcept Therapeutics with a lower beta; Amarillo Biosciences exhibits in...

 Which Small-Cap Medical Innovator Excels in Institutional Backing and Financial Performance?

Which Small-Cap Medical Innovator Excels in Institutional Backing and Financial Performance?

February 25, 2025 10:23 PM PST| By Team Kalkine Media

Highlights:,Higher institutional support observed in Telesis Bio (NASDAQ:TBIO) relative to Prenetics Global (NASDAQ:PRE).,Telesis Bio reports considerably greater revenue, while both companies operate at a deficit.,Prenetics Global exhibits steadier...

 Is This Biopharma Innovator Set for a Remarkable Quarter?

Is This Biopharma Innovator Set for a Remarkable Quarter?

February 25, 2025 10:22 PM PST| By Team Kalkine Media

Highlights:,Upcoming quarterly earnings report scheduled for the end of February featuring a minor loss per share alongside substantial revenue.,Active engagement in the biopharmaceutical sector with a focus on complement system inhibition to address...

 Which Small-Cap Medical Innovator Excels in Institutional Backing and Financial Performance?

Which Small-Cap Medical Innovator Excels in Institutional Backing and Financial Performance?

February 25, 2025 10:22 PM PST| By Team Kalkine Media

Highlights:,Higher institutional support observed in Telesis Bio (NASDAQ:TBIO) relative to Prenetics Global (NASDAQ:PRE).,Telesis Bio reports considerably greater revenue, while both companies operate at a deficit.,Prenetics Global exhibits steadier...

 Will Ascentage Pharma Ignite a New Wave in Biotech?

Will Ascentage Pharma Ignite a New Wave in Biotech?

February 25, 2025 10:20 PM PST| By Team Kalkine Media

Highlights:,Quiet period concluding in early March opens new channels for market communication.,Public offering in late January secured a substantial financial influx.,Firm headquartered in Suzhou, China, focuses on innovative treatments for serious...

 Is Myriad Genetics Facing Major Market Turbulence?

Is Myriad Genetics Facing Major Market Turbulence?

February 25, 2025 10:20 PM PST| By Team Kalkine Media

Highlights,Record annual low reached following a weak quarterly report,Financial results fell short of market expectations with negative margins,Institutional trading remains active amid challenging market conditions,Myriad Genetics (NASDAQ:MYGN) ope...

 Is Medpace Holdings (NASDAQ:MEDP) Gaining Momentum with Institutional Backing?

Is Medpace Holdings (NASDAQ:MEDP) Gaining Momentum with Institutional Backing?

February 25, 2025 09:55 AM PST| By Team Kalkine Media

Highlights,Sanctuary Advisors LLC expanded its stake in Medpace by 20.5% during the fourth quarter.,Hedge funds and institutional investors hold 77.98% of Medpace’s stock.,Medpace reported an EPS of $3.67, exceeding expectations.,Institutional Invest...

 How Is Amphastar Pharmaceuticals (NASDAQ:AMPH) Expanding Its Business Operations

How Is Amphastar Pharmaceuticals (NASDAQ:AMPH) Expanding Its Business Operations

February 25, 2025 09:48 AM PST| By Team Kalkine Media

Highlights,Institutional firms adjust their positions in Amphastar Pharmaceuticals.,Stock transactions reflect changes in market positioning.,Financial performance and market valuation updates reported.,Institutional Ownership,Amphastar Pharmaceutica...

 How Do Institutional Transactions Shape Chemed Corp (NYSE:CHE)

How Do Institutional Transactions Shape Chemed Corp (NYSE:CHE)

February 25, 2025 09:44 AM PST| By Team Kalkine Media

Highlights,Institutional firms adjust their positions in Chemed Corp.,Stock transactions reflect changes in market positioning.,Financial performance and market valuation updates reported.,Shifts in Institutional Investments,Chemed Corp,(NYSE:CHE),,...

 CVRx (NASDAQ:CVRX) How Its Innovations Are Shaping the Industry

CVRx (NASDAQ:CVRX) How Its Innovations Are Shaping the Industry

February 25, 2025 08:50 AM PST| By Team Kalkine Media

Highlights,CVRx has received varied stock recommendations, with multiple firms adjusting their ratings.,Institutional interest in CVRx has increased, with several firms expanding their positions.,The company specializes in neuromodulation devices des...

 How Has Vaxcyte (NASDAQ:PCVX) Stock Performed Amid Market Fluctuations

How Has Vaxcyte (NASDAQ:PCVX) Stock Performed Amid Market Fluctuations

February 25, 2025 08:49 AM PST| By Team Kalkine Media

Highlights,Vaxcyte receives coverage from multiple research firms, with price targets reflecting an optimistic outlook.,Institutional investment activity remains high, with hedge funds and asset management firms adjusting their holdings.,The company'...

 How Are Institutional Holdings in CareDx (NASDAQ:CDNA) Changing

How Are Institutional Holdings in CareDx (NASDAQ:CDNA) Changing

February 25, 2025 08:45 AM PST| By Team Kalkine Media

Highlights,CareDx, Inc. sees varied stock ratings, with price targets adjusted by multiple research firms.,Institutional investors are making strategic shifts in their holdings, with some increasing positions while others exit.,The company's portfoli...

Recent Articles






Investing Tips

Previous Next